Dr Anshul Agarwal Image

Dr Anshul Agarwal

MD ( medicine ), DM ( medical oncology )

Trained at the prestigious Tata Memorial Hospital, Mumbai, one of India’s leading cancer care institutions, I have received comprehensive training in medical oncology under the guidance of renowned experts in the field of cancer care.

I completed my M.D. in General Medicine from the prestigious SMS Medical College, Jaipur, followed by advanced super-specialty training (D.M.) in Medical Oncology at Tata Memorial Hospital, Mumbai. I began my career in medical oncology at the All India Institute of Medical Sciences (AIIMS), New Delhi, where I developed a strong foundation in the diagnosis and management of various cancers.

With over 10 years of experience in oncology, my approach combines clinical expertise, scientific knowledge, and compassionate patient care.

Alongside my clinical practice, I have a keen interest in cancer research and academic medicine. I have authored and contributed to multiple research publications in national and international journals, reflecting my commitment to advancing cancer care through evidence-based practice and scientific innovation.

I specialize in the diagnosis and treatment of a broad spectrum of solid tumors and blood cancers, caring for both adult and paediatric patients. My approach focuses on personalized treatment planning, considering each patient's diagnosis, disease stage, molecular profile, overall health, and individual needs.

Every cancer diagnosis is unique, and so is every patient's journey. My goal is to provide personalized, evidence-based, and compassionate cancer care, using the latest advances in medical oncology to identify the most appropriate treatment for each individual.

I believe that effective cancer care goes beyond treatment alone. It requires clear communication, informed decision-making, empathy, and continued support for patients and their families throughout their cancer journey.

Education:

  • 2005–2010: M.B.B.S. – S.P. Medical College, Bikaner
  • 2010–2015: M.D. – SMS Medical College, Jaipur
  • 2015–2016: Senior Residency (Medical Oncology) – AIIMS, New Delhi
  • 2016–2019: D.M. in Medical Oncology – Tata Memorial Hospital, Mumbai

Professional Memberships:

  • European Society for Medical Oncology (ESMO)
  • European Hematology Association (EHA)
  • American Society of Clinical Oncology (ASCO)
  • Indian Society of Medical and Paediatric Oncology (ISMPO)

Contributions at Tata Memorial Hospital, Mumbai:

  • Conducted a Phase I study on resveratrol and copper in autologous transplant myeloma patients under the mentorship of Prof. Navin Khatry.
  • Participated in the organization of support programs and meetings for sarcoma patients under the mentorship of Prof. Jyoti Bajpai.
  • Worked on the import of targeted agents on a compassionate basis, free of cost, for cancer patients with rare mutations at Tata Memorial Hospital, Mumbai, under the mentorship of Prof. Kumar and Prof. Jyoti Bajpai.

Research Publications:

  1. Agarwal A, Mital P, Goyal L, et al. A Study of Risk Factors and Impact of HAART on Blood Pressure in North Indians Living With HIV/AIDS. Scholars Academic Journal of Biosciences. 2015;3(1B):98–103.
  2. Agarwal A, Khandelwal A, Pal K, et al. A novel pro-oxidant combination of resveratrol and copper reduces transplant-related toxicities in patients receiving high-dose melphalan for multiple myeloma (RESCU001). PLoS ONE. 2022 Feb 4;17(2):e0262212. DOI: 10.1371.
  3. Roy S, Mandal T, Das S, Agarwal A, et al. Demography and pattern of care of patients with head-and-neck carcinoma: Experience from a tertiary care center in North India. DOI: 10.4103/crst.crst_286_20.
  4. Bajpai J, Abraham G, Agarwal A, Kapoor A, et al. Demographics, pattern of care, and outcome analysis of malignant melanoma cases from a tertiary care centre in India. Frontiers in Oncology. 2021;11:710585. DOI: 10.3389/fonc.2021.710585. View article
  5. Efficacy and tolerability of capecitabine and mitomycin-C-based concurrent radiotherapy in patients with anal canal cancer. Annals of Oncology. 2020;31(Suppl 6):S1283. DOI: 10.1016/j.annonc.2020.10.126. View publication

Awards:

  • Young Research Award – Winner, ISMPO – Shri Vijay Batra Research Foundation, 2022

Presentations:

  • A novel pro-oxidant combination of resveratrol and copper reduces transplant-related toxicities in patients receiving high-dose melphalan for multiple myeloma (RESCU001) – Poster presentation, EHA 2020 Virtual Congress.
  • Demographics, pattern of care, and outcome analysis of malignant melanoma cases from a tertiary care centre in India – Poster presentation, ESMO Asia 2020, Singapore.
  • An unusual case of Dandy-Walker syndrome – Poster presentation, APICON 2014.
  • A Study of Risk Factors and Impact of HAART on Blood Pressure in North Indians Living With HIV/AIDS – Oral presentation, APICON 2014.

Clinical Research:

Principal Investigator in various Phase I, Phase II, and Phase III clinical trials and bioequivalence studies.

Dr Dhruv Mehta Image

Dr Dhruv Mehta

MD ( medicine ), DM ( medical oncology )

Dr. Dhruv Mehta, born and brought up in Mumbai, has been fascinated with cancer since he was in Seth G. S. Medical College and KEM Hospital doing his MBBS. During his medical student days, he would assist in various cancer surgeries like mastectomies, Whipple’s procedures and colectomies. After completing his MBBS, he did his MD in Medicine from Baroda Medical College where he learned about chemotherapy and management of cancer under the existing SSG hospital oncology wing. During his MD days he completed first class Post graduate Program in Cardiology presented by John Hopkins University School of Medicine, Baltimore and The Medical Educational and Scientific Foundation of New York, Westbury, New York in April 2013, which later upped his interest in newer oncology subspeciality – cardio oncology. He is part of Asian CardioOncology Society since 2020

He did his Doctorate in Medicine (DM) in Oncology at Gujarat Cancer and Research Institute, Ahmedabad where he was exposed to various aspects of cancer care, including chemotherapy, targeted therapy, immunotherapy, pediatric oncology, hematology, oncopathology, bone marrow transplant and palliative care. After completion of DM, he shifted to Surat where he was just the third DM medical oncologist in the entire South Gujarat. Since then, he has worked at several esteemed institutions, including Shalby Hospital, SIDS Hospital, Haria LG Rotary Hospital (Vapi), BA Cancer Hospital (Navsari) and Amit Hospital (Valsad) where he has treated a diverse range of patients with various types of cancers, including breast cancer, lung cancer, colorectal cancer, and hematological malignancies. He has developed a strong foundation in managing complex difficult to treat cancer cases, and his patients appreciate his empathetic approach and ability to explain their diagnosis and treatment options in a clear and concise manner.

From 2017 to 2022, he had his own clinic – Om Cancer Centre, where he learned about intricacies of managing cancer patients in day care setting, leading to the successful establishment of South Gujarat Hematology and Oncology Centre in 2023, a 9-bed day care center along with his colleague, Dr. Ankit Parmar a reputed pediatric hematooncologist. He is an active Life Member of Association of Physicians of India, Life Member of Association of Medical Consultants, Mumbai. LM No. 0811 and Full member of American Society of Clinical Oncology (ASCO) since July 2015, ID: 506818. He has also presented cases and published research papers in peer-reviewed journals. In addition to his clinical work, he is passionate about educating patients and their families about cancer prevention, early detection, and treatment options. He has given talks and lectures on cancer awareness and have participated in cancer screening camps in underserved regions of South Gujarat. 

His approach to cancer care is holistic, focusing on the physical, emotional, and social well-being of his patients. He believes that every patient deserves personalized care, and he strives to provide compassionate and supportive care to each patient. In his free time, he enjoys reading medical literature, exploring new treatment options, and spending time with his family.